Biotoxtech Balance Sheet Health
Financial Health criteria checks 1/6
Biotoxtech has a total shareholder equity of ₩48.2B and total debt of ₩61.2B, which brings its debt-to-equity ratio to 126.9%. Its total assets and total liabilities are ₩147.0B and ₩98.8B respectively.
Key information
126.9%
Debt to equity ratio
₩61.23b
Debt
Interest coverage ratio | n/a |
Cash | ₩41.04b |
Equity | ₩48.23b |
Total liabilities | ₩98.80b |
Total assets | ₩147.04b |
Recent financial health updates
Is Biotoxtech (KOSDAQ:086040) A Risky Investment?
May 06Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?
Nov 30Recent updates
Is Biotoxtech (KOSDAQ:086040) A Risky Investment?
May 06Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)
Mar 28Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?
Feb 20Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?
Jan 24We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings
Dec 27Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?
Nov 30Financial Position Analysis
Short Term Liabilities: A086040's short term assets (₩64.7B) do not cover its short term liabilities (₩75.1B).
Long Term Liabilities: A086040's short term assets (₩64.7B) exceed its long term liabilities (₩23.7B).
Debt to Equity History and Analysis
Debt Level: A086040's net debt to equity ratio (41.9%) is considered high.
Reducing Debt: A086040's debt to equity ratio has increased from 46.9% to 126.9% over the past 5 years.
Debt Coverage: A086040's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A086040's interest payments on its debt are well covered by EBIT.